| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±3.9% | +3.9% | — |
| 05/07/2026 | ±2.3% | -21.5% | under-priced |
| 11/04/2025 | ±1.7% | -13.8% | under-priced |
| 08/05/2025 | ±2.3% | -3.8% | under-priced |
| 05/06/2025 | ±2.5% | -5.2% | under-priced |
| 11/04/2024 | ±2.1% | -3.7% | under-priced |
| 08/06/2024 | ±2.9% | +6.0% | under-priced |
| 05/02/2024 | ±2.8% | +5.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.65 | $2.5B | $691M |
| Q1 FY2026 | $1.42 | $2.3B | $601M |
| Q4 FY2025 | $1.37 | $2.4B | $603M |
| Q3 FY2025 | $1.63 | $2.4B | $721M |
ZOETIS INC. (ZTS) reports in 79 days, with the next report estimated for 11/30/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 7.9% on average — the market has tended to under-price ZTS's earnings risk. Fundamentals into the print: EPS up 2.5% year-over-year, revenue up 0.3%. QuantLogix's live 5-factor engine currently reads ZTS as a underweight at 33/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →